Spirig HealthCare AG - Oxycodon Naloxon Spirig HC 5 mg/2.5 mg, Retardtabletten | | 65931 | | 01 | | Oxycodon Naloxon Spirig HC 5 mg/2.5 mg | | Retardtabletten | | N02AA55 | | Oxycodone and Naloxone | | 16.03.2017 | | |
| Composition | oxycodoni hydrochloridum 5 mg, naloxoni hydrochloridum anhydricum 2.5 mg ut naloxoni hydrochloridum dihydricum, povidonum K 30, poly(vinylis acetas), povidonum K 27-32, natrii laurilsulfas, cellulosum microcristallinum, silica colloidalis anhydrica, magnesii stearas, Überzug: poly(alcohol vinylicus), talcum, macrogolum 3350, E 171, pro compresso obducto corresp. natrium 0.02 mg. | Packungsbestandteile | | Delayed release tablets | | | Active Agent | Dose |
---|
Naloxone Hydrochloride Anhydrate | 2.5 mg | Oxycodone Hydrochloride | 5 mg |
| BAG: Active Agent | Dose |
---|
Naloxone Hydrochloride Anhydrate | 2.5 mg | Oxycodone Hydrochloride | 5 mg |
| | Inactive agents | Dose | additional_information |
---|
| | | | | color. | Macrogol | 3350 | | | | | | | | | | Überzug | | | | | 27-32 | | | | | Silica Colloidalis Anhydrica | | | Talcum | | |
| |
| |
|